These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes? Talelli P; Greenwood RJ Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):387-405. PubMed ID: 19124436 [TBL] [Abstract][Full Text] [Related]
26. Secondary prevention of stroke with antiplatelet agents in patients with diabetes mellitus. Piechowski-Jozwiak B; Maulaz A; Bogousslavsky J Cerebrovasc Dis; 2005; 20 Suppl 1():15-23. PubMed ID: 16276081 [TBL] [Abstract][Full Text] [Related]
27. Outcome of carotid artery stenting for primary versus restenotic lesions. Cuadra S; Hobson RW; Lal BK; Goldstein J; Chakhtoura E; Jamil Z Ann Vasc Surg; 2009; 23(3):330-4. PubMed ID: 18692988 [TBL] [Abstract][Full Text] [Related]
28. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients? Rouhl RP; Lodder J Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236 [TBL] [Abstract][Full Text] [Related]
35. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience. Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885 [TBL] [Abstract][Full Text] [Related]
36. Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke. Douen AG; Medic S; Sabih M; Pageau N; Shuaib A J Stroke Cerebrovasc Dis; 2008; 17(6):356-9. PubMed ID: 18984426 [TBL] [Abstract][Full Text] [Related]
37. [A survey on cerebral infarction/transient ischemic attack inpatients compliance with secondary stroke prevention and follow-up 90 days]. Ma RH; Wang YJ; Wang CX; Zhao XQ; Wang YL; Xu MJ; Wei M; Li Y; Zhang Z; Zhang WW; Wang L; Lin L; Li HT; Zheng T; Wang XW; Li JJ; Lü Y; Qi D Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2618-22. PubMed ID: 19080709 [TBL] [Abstract][Full Text] [Related]
39. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention. Fuentes B; Ortega-Casarrubios MA; Martínez P; Díez-Tejedor E Cerebrovasc Dis; 2007; 24 Suppl 1():96-106. PubMed ID: 17971644 [TBL] [Abstract][Full Text] [Related]
40. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population. Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM; Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]